secwatch.observer — SEC 8-K summary
======================================

Issuer:     Curanex Pharmaceuticals Inc (CURX)
CIK:        0002025942
Form:       8-K
Filed at:   2026-09-04T20:15:30+00:00
Accession:  0001493152-26-041546
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Curanex regains Nasdaq minimum bid price compliance after 1-for-20 reverse split
--------------------------------------------------------------------------------

- On Sept 3, 2026, Nasdaq confirmed closing bid price >= $1.00 for 10 straight business days (Aug 20-Sep 2).
- Company effected 1-for-20 reverse stock split on Aug 20, 2026 to cure bid price deficiency.
- Originally notified Nov 5, 2025 of non-compliance with Nasdaq Listing Rule 5550(a)(2).
- Nasdaq has closed the matter; CURX remains listed on The Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2025942/000149315226041546/0001493152-26-041546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2025942/000149315226041546/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer